Media stories about Quintiles Transitional Holdings (NYSE:Q) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Quintiles Transitional Holdings earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 45 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:
- Quintiles Transitional Holdings Inc. (NYSE:Q) Earns Overweight Rating from Barclays PLC (americanbankingnews.com)
- Quintiles Transitional Holdings Inc. (NYSE:Q) Receives Average Recommendation of “Hold” from Brokerages (americanbankingnews.com)
- Billionaire Investors Backing A Marijuana Boom In 2017 (finance.yahoo.com)
- Analysts Poring Over the Numbers on Quintiles Transitional Holdings Inc. (NYSE:Q – Evergreen Caller (evergreencaller.com)
- EQT to acquire pharmaceutical services firm Certara – Reuters – Reuters (reuters.com)
A number of analysts have recently commented on Q shares. Citigroup Inc. restated a “neutral” rating and set a $96.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a report on Wednesday, June 28th. Robert W. Baird raised shares of Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and upped their price target for the stock from $76.00 to $93.00 in a research report on Friday, July 7th. Jefferies Group LLC reaffirmed a “hold” rating and set a $78.00 price target on shares of Quintiles Transitional Holdings in a research report on Monday, April 3rd. Zacks Investment Research cut shares of Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, April 26th. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $96.00 price objective (up from $94.00) on shares of Quintiles Transitional Holdings in a research report on Tuesday, June 6th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $87.47.
Quintiles Transitional Holdings (NYSE:Q) opened at 90.08 on Tuesday. The stock’s 50 day moving average is $86.48 and its 200-day moving average is $80.79. The company has a market cap of $19.82 billion, a P/E ratio of 199.29 and a beta of 0.64. Quintiles Transitional Holdings has a 12-month low of $70.10 and a 12-month high of $91.81.
Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings results on Wednesday, May 3rd. The medical research company reported $1.01 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.06. The business had revenue of $1.91 billion for the quarter, compared to the consensus estimate of $1.91 billion. Quintiles Transitional Holdings had a net margin of 1.06% and a return on equity of 18.03%. Quintiles Transitional Holdings’s revenue was up 72.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.89 earnings per share. Analysts predict that Quintiles Transitional Holdings will post $4.54 earnings per share for the current fiscal year.
Quintiles Transitional Holdings announced that its board has authorized a share repurchase plan on Wednesday, May 24th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the medical research company to repurchase up to 5.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its stock is undervalued.
In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of Quintiles Transitional Holdings stock in a transaction on Wednesday, May 31st. The shares were sold at an average price of $84.01, for a total transaction of $599,089,171.65. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director John G. Danhakl sold 761,143 shares of Quintiles Transitional Holdings stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $84.01, for a total value of $63,943,623.43. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,758,400 shares of company stock valued at $735,783,985. 6.40% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Quintiles Transitional Holdings (NYSE:Q) Stock Price” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.chaffeybreeze.com/2017/07/18/quintiles-transitional-holdings-q-given-coverage-optimism-rating-of-0-07-updated-updated-updated.html.
Quintiles Transitional Holdings Company Profile
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.